Streetbeat News

Analyst Ratings

CCL

Barclays has maintained its Overweight rating for Carnival (NYSE:CCL) and raised its price target from $13.00 to $18.00. Carnival's shares are currently trading at $15.81, down 0.57% over the last 24 hours.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:02 pm

COHR

Rosenblatt downgraded Coherent (NYSE:COHR) to Neutral with a price target of $55.00, up from $41.00. Coherent's shares are trading down 13.72% at $47.72 per share.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:02 pm

WCC

Over the past 3 months, 6 analysts have published their opinion on WESCO Intl (NYSE:WCC) stock, with 1 bullish and 5 somewhat bullish ratings. The average 12-month price target is $191.17, up 0.62% from the previous average of $190.00.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:01 pm

CPRX

Truist Securities maintains its Buy rating for Catalyst Pharmaceuticals (NASDAQ:CPRX) and raises its price target from $22.00 to $24.00. Catalyst Pharmaceuticals shares are trading up 3.13% at $13.02 per share.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:01 pm

NKE

Telsey Advisory Group maintains its Outperform rating for Nike (NYSE:NKE) but lowers its price target from $140 to $135. Nike's shares are trading up 0.39% at $109.97, and a move to $135 would account for a 22.76% increase.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:01 pm

OHI

In the last 3 months, 6 analysts have offered 12-month price targets for Omega Healthcare Invts (NYSE:OHI), with an average price target of $30.67, a 3.4% decrease from the previous average of $31.75.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:01 pm

CTVA

In the last quarter, Corteva (NYSE:CTVA) received 6 bullish analyst ratings with an average 12-month price target of $74.17, down 3.05% from the previous average of $76.50.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:01 pm

PRTA

In the last 3 months, 8 analysts have offered 12-month price targets for Prothena Corp (NASDAQ:PRTA), with an average price target of $86.38. The average price target has increased by 13.66% over the past month.

Portfolio Pulse from Benzinga Insights

June 21, 2023 | 5:00 pm

OHI

Truist Securities analyst Michael Lewis maintains a Hold rating on Omega Healthcare Invts (NYSE:OHI) and raises the price target from $29 to $33.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 4:58 pm

CPRX

Truist Securities analyst Joon Lee maintains a Buy rating on Catalyst Pharmaceuticals (NASDAQ:CPRX) and raises the price target from $22 to $24.

Portfolio Pulse from Benzinga Newsdesk

June 21, 2023 | 4:56 pm